Matthew J. Ahearne

971 total citations
26 papers, 499 citations indexed

About

Matthew J. Ahearne is a scholar working on Pathology and Forensic Medicine, Immunology and Genetics. According to data from OpenAlex, Matthew J. Ahearne has authored 26 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pathology and Forensic Medicine, 16 papers in Immunology and 10 papers in Genetics. Recurrent topics in Matthew J. Ahearne's work include Lymphoma Diagnosis and Treatment (19 papers), Chronic Lymphocytic Leukemia Research (9 papers) and CAR-T cell therapy research (6 papers). Matthew J. Ahearne is often cited by papers focused on Lymphoma Diagnosis and Treatment (19 papers), Chronic Lymphocytic Leukemia Research (9 papers) and CAR-T cell therapy research (6 papers). Matthew J. Ahearne collaborates with scholars based in United Kingdom, Australia and Canada. Matthew J. Ahearne's co-authors include Simon D. Wagner, Christopher P. Fox, Paul Ko Ferrigno, Shaun Willimott, Martin J.S. Dyer, Fiona Miall, Kikkeri N. Naresh, Hazem Ibrahim, Victoria Adams and Daniel Beck and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Matthew J. Ahearne

23 papers receiving 496 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew J. Ahearne United Kingdom 13 264 257 194 117 85 26 499
Lori A. Leslie United States 11 252 1.0× 168 0.7× 84 0.4× 125 1.1× 61 0.7× 73 412
Noboru Yonetani Japan 9 192 0.7× 292 1.1× 69 0.4× 174 1.5× 62 0.7× 21 388
Barbara Petit France 10 383 1.5× 447 1.7× 258 1.3× 82 0.7× 90 1.1× 12 664
Miguel Islas‐Ohlmayer United States 7 223 0.8× 225 0.9× 119 0.6× 68 0.6× 32 0.4× 16 435
Hiroshi Gomyo Japan 10 207 0.8× 233 0.9× 126 0.6× 47 0.4× 61 0.7× 19 386
Annette Lake United Kingdom 11 347 1.3× 286 1.1× 150 0.8× 37 0.3× 57 0.7× 13 495
Steve Shuey United States 5 144 0.5× 250 1.0× 153 0.8× 156 1.3× 68 0.8× 5 430
H Stein Germany 7 136 0.5× 222 0.9× 137 0.7× 105 0.9× 80 0.9× 15 380
Gregorio Barilà Italy 16 142 0.5× 186 0.7× 250 1.3× 207 1.8× 109 1.3× 38 509
JP Greer United States 6 265 1.0× 138 0.5× 118 0.6× 88 0.8× 87 1.0× 8 452

Countries citing papers authored by Matthew J. Ahearne

Since Specialization
Citations

This map shows the geographic impact of Matthew J. Ahearne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew J. Ahearne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew J. Ahearne more than expected).

Fields of papers citing papers by Matthew J. Ahearne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew J. Ahearne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew J. Ahearne. The network helps show where Matthew J. Ahearne may publish in the future.

Co-authorship network of co-authors of Matthew J. Ahearne

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew J. Ahearne. A scholar is included among the top collaborators of Matthew J. Ahearne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew J. Ahearne. Matthew J. Ahearne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jayne, Sandrine, Matthew J. Ahearne, Sai Duraisingham, et al.. (2024). Monitoring of molecular responses to tirabrutinib in a cohort of exceptional responders with relapsed/refractory mantle cell lymphoma. SHILAP Revista de lepidopterología. 5(4). 896–899. 1 indexed citations
2.
Jayne, Sandrine, Cristina López, Inga Nagel, et al.. (2024). The chromosomal translocation t (1;6)(p35.3;p25.2), recurrent in chronic lymphocytic leukaemia, leads to RCC1 :: IRF4 fusion. British Journal of Haematology. 205(6). 2321–2326.
3.
Fox, Christopher P., Matthew J. Ahearne, Ruth Pettengell, et al.. (2021). Guidelines for the management of mature T‐ and natural killer‐cell lymphomas (excluding cutaneous T‐cell lymphoma): a British Society for Haematology Guideline. British Journal of Haematology. 196(3). 507–522. 17 indexed citations
4.
Dillon, Richard, Matthew J. Ahearne, Lynn Quek, et al.. (2021). Therapy-related leukaemias with balanced translocations can arise from pre-existing clonal haematopoiesis. Leukemia. 35(8). 2407–2411. 3 indexed citations
5.
Lim, Sean H., Nicola Campbell, Marina Johnson, et al.. (2021). Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma. The Lancet Haematology. 8(8). e542–e544. 47 indexed citations
6.
Martínez‐Calle, Nicolás, Amy A. Kirkwood, Maxine Lamb, et al.. (2021). Systemic ALCL Treated in Routine Clinical Practice: Outcomes Following First-Line Chemotherapy from a Multicentre Cohort. Advances in Therapy. 38(7). 3789–3802. 3 indexed citations
7.
Wilson, Matthew R., Toby A. Eyre, Nicolás Martínez‐Calle, et al.. (2020). Timing of high-dose methotrexate CNS prophylaxis in DLBCL: an analysis of toxicity and impact on R-CHOP delivery. Blood Advances. 4(15). 3586–3593. 32 indexed citations
8.
Wagner, Simon D., et al.. (2020). The new biology of PTCL‐NOS and AITL: current status and future clinical impact. British Journal of Haematology. 189(1). 54–66. 39 indexed citations
9.
Ahearne, Matthew J., Charlotte Gaskell, Aimee Jackson, et al.. (2020). AVAIL-T: A Phase 2a Trial of Avelumab, and Anti-PD-L1 Antibody, in Relapsed and Refractory Peripheral T-Cell Lymphoma (PTCL). Blood. 136(Supplement 1). 18–19. 4 indexed citations
10.
Carr, Matthew, et al.. (2019). Interleukin-2–inducible T-cell kinase inhibitors modify functional polarization of human peripheral T-cell lymphoma cells. Blood Advances. 3(5). 705–710. 5 indexed citations
11.
Kelly, Michael, et al.. (2019). Structural and diffusion weighted MRI demonstrates responses to ibrutinib in a mouse model of follicular helper (Tfh) T-cell lymphoma. PLoS ONE. 14(4). e0215765–e0215765. 4 indexed citations
12.
13.
Walter, Harriet S., Matthew J. Ahearne, Sandrine Jayne, et al.. (2019). Successful Treatment of Primary Cutaneous Diffuse Large B-Cell Lymphoma Leg Type With Single-Agent Venetoclax. JCO Precision Oncology. 3(3). 1–5. 7 indexed citations
14.
Ahearne, Matthew J., et al.. (2018). Comparison of interleukin-2-inducible kinase (ITK) inhibitors and potential for combination therapies for T-cell lymphoma. Scientific Reports. 8(1). 14216–14216. 27 indexed citations
15.
Kotecha, Deevia, et al.. (2018). PD1hi cells associate with clusters of proliferating B-cells in marginal zone lymphoma. Diagnostic Pathology. 13(1). 74–74. 5 indexed citations
16.
Martínez‐Calle, Nicolás, Sarah Hartley, Matthew J. Ahearne, et al.. (2018). Kinetics of T‐cell subset reconstitution following treatment with bendamustine and rituximab for low‐grade lymphoproliferative disease: a population‐based analysis. British Journal of Haematology. 184(6). 957–968. 33 indexed citations
17.
18.
Ahearne, Matthew J., et al.. (2014). Expression of PD-1 (CD279) and FoxP3 in diffuse large B-cell lymphoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 465(3). 351–358. 57 indexed citations
19.
Willimott, Shaun, Daniel Beck, Matthew J. Ahearne, Victoria Adams, & Simon D. Wagner. (2013). Cap-Translation Inhibitor, 4EGI-1, Restores Sensitivity to ABT-737 Apoptosis through Cap-Dependent and -Independent Mechanisms in Chronic Lymphocytic Leukemia. Clinical Cancer Research. 19(12). 3212–3223. 29 indexed citations
20.
Wagner, Simon D., Matthew J. Ahearne, & Paul Ko Ferrigno. (2010). The role of BCL6 in lymphomas and routes to therapy. British Journal of Haematology. 152(1). 3–12. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lori A. Leslie Breakdown of academic impact, for papers by Noboru Yonetani Breakdown of academic impact, for papers by Barbara Petit Breakdown of academic impact, for papers by Miguel Islas‐Ohlmayer Breakdown of academic impact, for papers by Hiroshi Gomyo Breakdown of academic impact, for papers by Annette Lake Breakdown of academic impact, for papers by Steve Shuey Breakdown of academic impact, for papers by H Stein Breakdown of academic impact, for papers by Gregorio Barilà Breakdown of academic impact, for papers by JP Greer
Rankless by CCL
2026